The present study shows increased lipofuscin and malondialdehyde, and reduced GST and GR activity, in erythrocytes from ARDS patients affected by COVID-19, suggesting that the severity of COVID-19—with respect to typical ARDS—is associated with erythrocyte oxidative stress. This evidence concerns the gene GSR and COVID-19.